SCHEMBL24967942

SCHEMBL24967942

COc1ncc(CC(C)=O)cc1C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
CFTR P13569 3/20 0.37
MAPT P10636 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
AURKA O14965 1/20 0.36
KDR P35968 1/20 0.36
AURKB Q96GD4 1/20 0.36
CYP3A4 P08684 1/20 0.35
PIK3CD O00329 6/20 0.35
PIK3CA P42336 3/20 0.35
PIK3CB P42338 2/20 0.35
PIK3CG P48736 2/20 0.35
POLB P06746 1/20 0.34
S1PR1 P21453 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30851110 1.00 LMNA (0.39) LMNACFTRMAPTSMN1; SMN2AURKA
SCHEMBL30851253 0.88 SMN1; SMN2 (0.47) LMNASMN1; SMN2S1PR1GAA
SCHEMBL24967935 0.88 SMN1; SMN2 (0.47) LMNASMN1; SMN2S1PR1GAA
SCHEMBL29165958 0.86 LMNA (0.41) LMNACFTRMAPTSMN1; SMN2AURKA
SCHEMBL24967939 0.82 HDAC4 (0.44) LMNACFTRMAPTSMN1; SMN2KDM4E
SCHEMBL29208803 0.81 AURKA (0.39) LMNACFTRMAPTAURKAKDR
SCHEMBL21031170 0.80 AURKA (0.40) LMNACFTRMAPTAURKAKDR
SCHEMBL24968231 0.79 AURKA (0.37) LMNACFTRMAPTAURKAKDR
SCHEMBL24968228 0.79 AURKA (0.37) LMNACFTRMAPTAURKAKDR
SCHEMBL30851115 0.79 AURKA (0.37) LMNACFTRMAPTAURKAKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117642393-A Novel PARP7 inhibitor and application thereof 上海齐鲁制药研究中心有限公司 2024-03-01 CN disclosed
WO-2023006013-A1 NOVEL PARP7 INHIBITOR AND USE THEREOF 上海齐鲁制药研究中心有限公司 2023-02-02 WO disclosed